Please contact Jörn Aldag with any inquiries.


Date Title
Hookipa Secures EUR 4.16 million Additional Grant Support from the Austrian Research Promotion Agency (FFG) to Develop Arenavirus Vector-Based Cancer Immunotherapies
Dr. Torsten Mummenbrauer Appointed SVP Business Development & Licensing of Hookipa Biotech
Hookipa Biotech Initiates First-in-Human Study of Cytomegalovirus Vaccine
Jörn Aldag Appointed CEO of Hookipa Biotech
Hookipa to present at Biotech in Europe Forum 2015
Hookipa receives additional grant support from FFG for development of vaccine candidate HB101


Date Title

ESMO Immuno Oncology Congress 2017

Geneva, Switzerland

Jefferies Conference

London, United Kingdom

Bio Europe

Berlin, Germany

ICI Europe 2017

Munich, Germany

World Vaccine Congress

Barcelona, Spain

Scientific Colloquium on Heterologous Prime‑boost Vaccination

Leuven, Belgium

Sachs Forum for Global Partnering and Investment

Basel, Switzerland

2nd annual Cancer Immunotherapy Summit

Vienna, Austria

Annual Vaccine Day

Utrecht, The Netherlands

CIMT 2017

Mainz, Germany

12th Immuno-Oncology Summit

Boston, USA

Medicxi Forum

Monte Carlo, Monaco

International Herpesvirus Workshop

Ghent, Belgium

15th Annual Vaccines Research & Development Conference

Baltimore, USA


San Diego, USA

ASCO 2017

Chicago, USA

UBS Global Healthcare Conference

New York, USA

BioEquity Europe 2017

Paris, France

2nd Annual Advances in Immuno-Oncology Congress

UK, London

6th International Congenital CMV Conference

Noordwijkerhout, The Netherlands

10th Annual European Life Sciences CEO Forum & Exhibition

Zurich, Switzerland

J.P. Morgan 35th Annual Healthcare Conference

San Francisco, CA, USA